Share this to:

Support & Insight for the Autumn of Life

How the Alzheimer’s Gene Breaks the Brain

Until now, scientists were unsure about how APOE4 creates the strongest genetic risk factor in Alzheimer's. Now they believe they know.
Public%2BDomain%2BPictures%2B-%2BDNA%2B-%2BPixabay.jpeg

Researchers at USC have revealed how APOE4, a genetic culprit for Alzheimer’s disease, triggers leaks in the brain’s plumbing system, allowing toxic substances to seep into the brain areas responsible for memory encoding and other cognitive functions.

The damage is linked to future problems in learning and memory, even when the disease’s signature sticky plaques have not appeared. The findings suggest that the smallest blood vessels in the brain, which form the blood-brain barrier, might be a potential target for early treatment.

The study appears in Nature.

Researchers looked at the blood vessels

“This study sheds light on a new way of looking at this disease and possibly treatment in people with the APOE4 gene, looking at blood vessels and improving their function to potentially slow down or arrest cognitive decline,” said senior author Berislav Zlokovic, director of the Zilkha Neurogenetic Institute at the Keck School of Medicine of USC.

“Severe damage to vascular cells called pericytes was linked to more severe cognitive problems in APOE4 carriers. APOE4 seems to speed up breakdown of the blood-brain barrier by activating an inflammatory pathway in blood vessels, which is associated with pericyte injury.”

Scientists have long known that the APOE4 gene — which occurs in up to 14 percent of the population — increases the probability of developing Alzheimer’s disease. Until now, it’s been unclear how different pathologies determine the course of the disease in its early stages, or what underlying mechanisms lead to cognitive decline in APOE4 carriers.

Early onset linked to pericyte damage

Zlokovic’s previous research showed that people who develop early memory problems also experience the most leakage in their brain’s blood vessels — independent of amyloid plaque or tau, two common contributors to Alzheimer’s.

The leakage starts when cells called pericytes, which line the walls of blood vessels in the brain and maintain blood-brain barrier integrity, are damaged. These injured pericytes can be detected with a unique biomarker, developed by Zlokovic’s lab in 2015, which shows up in cerebrospinal fluid.

For this study, scientists used standard memory tests to check the participants’ cognitive abilities and their neuropsychological performance. They also used advanced neuroimaging and employed the biomarker that indicates damage to the brain’s blood vessels.

Damaged capillaries an early warning

In participants who had the APOE4 gene, researchers found damaged capillaries in the brain’s memory center, the hippocampus and medial temporal lobe.

The damage correlated with increased levels of a protein that causes inflammation, cyclophilin A — an early sign of the disease in people already at higher risk of developing Alzheimer’s.

Zlokovic, who became director of the Zilkha Neurogenetic Institute in 2012, pioneered the concept that a breakdown in the blood-brain barrier contributes to cognitive impairment and dementia.

The Zilkha Neurogenetic Institute opened at Keck School of Medicine in 2003 with a $20 million donation from Los Angeles businessman Selim Zilkha, who later contributed $10 million more to the effort.


MORE INFO:

The Zilkha Neurogenetic Institute opened at Keck School of Medicine in 2003 with a $20 million donation from Los Angeles businessman Selim Zilkha, who later contributed $10 million more to the effort.

SOURCE:

REFERENCE:

  • Axel Montagne, Daniel A. Nation, Abhay P. Sagare, Giuseppe Barisano, Melanie D. Sweeney, Ararat Chakhoyan, Maricarmen Pachicano, Elizabeth Joe, Amy R. Nelson, Lina M. D’Orazio, David P. Buennagel, Michael G. Harrington, Tammie L. S. Benzinger, Anne M. Fagan, John M. Ringman, Lon S. Schneider, John C. Morris, Eric M. Reiman, Richard J. Caselli, Helena C. Chui, Julia TCW, Yining Chen, Judy Pa, Peter S. Conti, Meng Law, Arthur W. Toga, Berislav V. Zlokovic. APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature, 2020; DOI: 10.1038/s41586-020-2247-3
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
B. Berger

B. Berger

Visit Our Pages On:

Welcome

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Related

person wearing hearing aid
Can Hearing Aids Diminish Dementia?
Hearing loss and dementia may be linked, but there is a silver lining here.
Black tweezers on white background.
CLR01 Beats Curcumin in Blocking Alzheimer's
CLR01, a "molecular tweezer", keeps brain proteins from the clumping, or aggregating, that causes Alzheimer's, Parkin...
Photo Of Man Sitting On A PET Scanner
Amyloid PET Scan Coverage Approved at Last
Amyloid Scans diagnose and treat Alzheimer's, at a hefty price. 11 years after FDA approval, Medicare can finally help.
0
Would love your thoughts, please comment.x
()
x
News, Treatments, Care Tips

Subscribe To The Weekly Newsletter

videos & articles on Research & Prevention
News to Get at the Truth

Subscribe To Our Weekly Newsletter